Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Brain Pathology

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bpa.12487PMID 28117910PMCID PMC8028631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis.

  2016cited by this paper
• Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS

  2016cited by this paper
• Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic stroke.

  2016cited by this paper
• Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9

  2015cited by this paper
• Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination

  2014cited by this paper
• Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors.

  2014influential reference
• Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System

  2013cited by this paper
• Regulation of Adaptive Immunity by the Fractalkine Receptor during Autoimmune Inflammation

  2013cited by this paper
• Suppression of Inflammatory Responses during Myelin Oligodendrocyte Glycoprotein–Induced Experimental Autoimmune Encephalomyelitis Is Regulated by AKT3 Signaling

  2013cited by this paper
• Exploring mechanisms of FGF signalling through the lens of structural biology

  2013cited by this paper
• FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.

  2013cited by this paper
• ERK1/ERK2 MAPK Signaling is Required to Increase Myelin Thickness Independent of Oligodendrocyte Differentiation and Initiation of Myelination

  2012cited by this paper
• Serum and CSF PDGF‐AA and FGF‐2 in relapsing‐remitting multiple sclerosis: a case–control study

  2012cited by this paper
• The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.

  2012cited by this paper
• Analysis of the Fibroblast Growth Factor System Reveals Alterations in a Mouse Model of Spinal Muscular Atrophy

  2012cited by this paper
• Macrophages Promote Fibroblast Growth Factor Receptor-Driven Tumor Cell Migration and Invasion in a Cxcr2-Dependent Manner

  2012cited by this paper
• Fibroblast Growth Factor Receptor Signaling in Oligodendrocytes Regulates Myelin Sheath Thickness

  2012cited by this paper
• Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis

  2012cited by this paper
• Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination.

  2012influential reference
• Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner

  2012cited by this paper
• Role of fibroblast growth factor receptors in astrocytic stem cells.

  2012cited by this paper
• Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination

  2011cited by this paper
• Neuroprotective role of fibroblast growth factor‐2 in experimental autoimmune encephalomyelitis

  2011influential reference
• The ERK2 Mitogen-Activated Protein Kinase Regulates the Timing of Oligodendrocyte Differentiation

  2011cited by this paper
• FGF-dependent regulation of VEGF receptor 2 expression in mice.

  2011cited by this paper
• FGF-2 and Anosmin-1 Are Selectively Expressed in Different Types of Multiple Sclerosis Lesions

  2011influential reference
• Reduced Axonopathy and Enhanced Remyelination After Chronic Demyelination in Fibroblast Growth Factor 2 (Fgf2)-Null Mice: Differential Detection With Diffusion Tensor Imaging

  2011cited by this paper
• Fibroblast growth factor signalling: from development to cancer

  2010cited by this paper
• Elevated Phosphatidylinositol 3,4,5-Trisphosphate in Glia Triggers Cell-Autonomous Membrane Wrapping and Myelination

  2010cited by this paper
• Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.

  2010cited by this paper
• Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.

  2010cited by this paper
• T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

  2010cited by this paper
• LINGO‐1 negatively regulates TrkB phosphorylation after ocular hypertension

  2010cited by this paper
• Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination

  2010cited by this paper
• Akt Signals through the Mammalian Target of Rapamycin Pathway to Regulate CNS Myelination

  2009influential reference
• Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis

  2009cited by this paper
• Remyelination protects axons from demyelination-associated axon degeneration.

  2008cited by this paper
• Constitutively Active Akt Induces Enhanced Myelination in the CNS

  2008influential reference
• Up‐regulation of brain‐derived neurotrophic factor by application of fibroblast growth factor‐2 to the cut optic nerve is important for long‐term survival of retinal ganglion cells

  2008cited by this paper
• Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.

  2008cited by this paper
• Nogo-A is a Reliable Oligodendroglial Marker in Adult Human and Mouse CNS and in Demyelinated Lesions

  2007influential reference
• LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

  2007influential reference
• Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis

  2007cited by this paper
• ERK1−/− Mice Exhibit Th1 Cell Polarization and Increased Susceptibility to Experimental Autoimmune Encephalomyelitis1

  2006cited by this paper
• Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

  2006influential reference
• Fibroblast growth factor 2 applied to the optic nerve after axotomy up‐regulates BDNF and TrkB in ganglion cells by activating the ERK and PKA signaling pathways

  2006cited by this paper
• Transcription factor co‐expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord

  2006cited by this paper
• Endogenous Cell Repair of Chronic Demyelination

  2006cited by this paper
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes CONSEQUENCES FOR MOTOR NEURON SURVIVAL*

  2005cited by this paper
• LINGO-1 negatively regulates myelination by oligodendrocytes

  2005cited by this paper
• Distinct Fibroblast Growth Factor (FGF)/FGF Receptor Signaling Pairs Initiate Diverse Cellular Responses in the Oligodendrocyte Lineage

  2005cited by this paper
• CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.

  2005cited by this paper
• Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo.

  2005cited by this paper
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes

  2005cited by this paper
• Neurotrophins and their receptors: A convergence point for many signalling pathways

  2003cited by this paper
• Fibroblast growth factors and their receptors in the central nervous system

  2003cited by this paper
• CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.

  2003cited by this paper
• Neurotrophic factors and axonal growth.

  2002cited by this paper
• BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

  2002cited by this paper
• Absence of Fibroblast Growth Factor 2 Promotes Oligodendroglial Repopulation of Demyelinated White Matter

  2002cited by this paper
• FGF Induces a Switch in Death Receptor Pathways in Neuronal Cells

  2001cited by this paper
• Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice

  2001cited by this paper
• Role for basic fibroblast growth factor (FGF-2) in tyrosine kinase (TrkB) expression in the early development and innervation of the auditory receptor: in vitro and in situ studies.

  2000cited by this paper
• Cell signaling by receptor tyrosine kinases.

  2000cited by this paper
• Cell signaling by receptor tyrosine kinases.

  2000cited by this paper
• Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

  1999cited by this paper
• Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: Temporally distinct expression of midkine and pleiotrophen

  1998cited by this paper
• Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis

  1998cited by this paper
• FGF‐2 converts mature oligodendrocytes to a novel phenotype

  1997cited by this paper
• Expression and functional expansion of fibroblast growth factor receptor T cells in rheumatoid synovium and peripheral blood of patients with rheumatoid arthritis.

  1996cited by this paper
• Signaling by Receptor Tyrosine Kinases

  1993cited by this paper
• Structural and functional diversity in the FGF receptor multigene family.

  1993cited by this paper

• FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems

  2025cites this paper
• Growth under serial stocking density and transcriptome analysis of the brain in rainbow trout Oncorhynchus mykiss

  2025cites this paper
• Immunomodulatory Potential of Escitalopram on C‐C Motif Chemokine Ligand 5 and Fibroblast Growth Factor 2 in Patients With Generalised Anxiety Disorder

  2025cites this paper
• Molecular mechanism and the main signaling pathways in the development and progression of Multiple Sclerosis.

  2025cites this paper
• Network pharmacology, molecular docking, and experimental validation to explore dihydromyricetin attenuates LPS-induced acute lung injury by promoting FGFR1

  2025cites this paper
• Mutations in the human CSF1R gene impact microglia’s maintenance of brain white matter integrity

  2025cites this paper
• FGFR1 agonists alleviate pathology and cognitive impairment in an Alzheimer's disease mouse model.

  2025cites this paper
• The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI

  2024cites this paper
• Ginsenoside reprogramming microglia through the FGF/FGFR1 inhibits post traumatic stress disorder.

  2024cites this paper
• Cell surface receptor-mediated signaling in CNS regeneration.

  2024cites this paper
• Fibroblast growth factor receptor inhibitors mitigate the neuropathogenicity of Borrelia burgdorferi or its remnants ex vivo

  2024cites this paper
• The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti‐inflammatory effects and remyelination in a model of multiple sclerosis

  2023cites this paper
• FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis

  2023cites this paper
• A novel cell-free intrathecal approach with PRP for the treatment of spinal cord multiple sclerosis in cats

  2022cites this paper
• New developments in the biology of fibroblast growth factors.

  2022cites this paper
• Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis

  2022cites this paper
• Chronic oligodendrocyte injury in central nervous system pathologies

  2022cites this paper
• Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant

  2021cites this paper
• Prevention of Vascular Dementia via Immunotherapeutic Blockade of Renin-Angiotensin System in a Rat Model.

  2021cites this paper
• Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE

  2021cites this paper
• Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes

  2021influential citation
• Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway

  2021cites this paper
• FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models

  2021influential citation
• Fibroblast Growth Factor Signalling in the Diseased Nervous System

  2021cites this paper
• Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG35‐55‐induced EAE through ERK and Akt signalling

  2020cites this paper
• The combined treatment of NAD+ and atorvastatin ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.

  2020cites this paper
• Graphene quantum dots inhibit T cell‐mediated neuroinflammation in rats

  2019cites this paper
• The therapeutic effect of platelet-rich plasma on the experimental autoimmune encephalomyelitis mice.

  2019cites this paper
• Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential

  2019cites this paper
• The Bu Shen Yi Sui Formula Promotes Axonal Regeneration via Regulating the Neurotrophic Factor BDNF/TrkB and the Downstream PI3K/Akt Signaling Pathway

  2019cites this paper
• Integrative Computational Network Analysis Reveals Site-Specific Mediators of Inflammation in Alzheimer's Disease

  2018influential citation
• A Genome Model to Explain Major Features of Neurodevelopmental Disorders

  2018cites this paper